Literature DB >> 22807950

Identification of multiple pathways involved in the malignant transformation of endometriosis (Review).

Yumi Higashiura1, Hirotaka Kajihara, Hiroshi Shigetomi, Hiroshi Kobayashi.   

Abstract

The association between endometriosis and malignant transformation has often been described in the medical literature. A search was conducted between 1966 and 2010 through the English language literature (online Medline PubMed database) using the keywords endometriosis combined with malignant transformation. The search revealed an increase in reports describing endometriosis and malignancy. Approximately 1.0% of women with endometriosis have lesions that undergo malignant transformation. The malignant processes that are associated with endometriosis may be classified into three groups: i) epithelial ovarian cancers (endometrioid adenocarcinoma and clear cell carcinoma), ii) other Müllerian-type tumors, including Müllerian-type mucinous borderline tumor and serous borderline tumor and iii) sarcomas such as adenosarcoma and endometrial stromal sarcoma in the female pelvic cavity. Persistent oxidative stress induced by endometriosis-dependent hemorrhage may be associated with carcinogenesis. In conclusion, the malignant transformation of endometriosis has multiple pathways of development and may share a common pathogenic mechanism; iron-induced oxidative stress derived from repeated hemorrhage.

Entities:  

Year:  2012        PMID: 22807950      PMCID: PMC3398349          DOI: 10.3892/ol.2012.690

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  73 in total

Review 1.  Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary.

Authors:  Yoshihiko Yamada; Hiroshi Shigetomi; Akira Onogi; Shoji Haruta; Ryuji Kawaguchi; Shozo Yoshida; Naoto Furukawa; Akira Nagai; Yasuhito Tanase; Taihei Tsunemi; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Int J Gynecol Cancer       Date:  2011-10       Impact factor: 3.437

Review 2.  Cancer and endometriosis: do we need to be concerned?

Authors:  D C Martin
Journal:  Semin Reprod Endocrinol       Date:  1997

3.  Müllerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of müllerian mixed tumor.

Authors:  P B Clement; R E Scully
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan.

Authors:  H Kobayashi; K Sumimoto; N Moniwa; M Imai; K Takakura; T Kuromaki; E Morioka; K Arisawa; T Terao
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

5.  Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.

Authors:  Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard Roden; Ruth Glas; Dennis Slamon; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Science       Date:  2010-09-08       Impact factor: 47.728

Review 6.  Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findings.

Authors:  Takuya Moriya; Yoshiki Mikami; Kazuhiro Sakamoto; Mareyuki Endoh; Junji Takeyama; Takashi Suzuki; Shizue Mochizuki; Mika Watanabe; Yasumasa Monobe; Hironobu Sasano
Journal:  Med Electron Microsc       Date:  2003-12

7.  Cancers, infections, and endocrine diseases in women with endometriosis.

Authors:  Julie Anne L Gemmill; Pamela Stratton; Sean D Cleary; Mary Lou Ballweg; Ninet Sinaii
Journal:  Fertil Steril       Date:  2009-11-27       Impact factor: 7.329

Review 8.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

9.  Endometriosis and ovarian cancer: a systematic review.

Authors:  Ahmad Sayasneh; Dimitris Tsivos; Robin Crawford
Journal:  ISRN Obstet Gynecol       Date:  2011-07-15

10.  KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.

Authors:  Veronika Auner; Gernot Kriegshäuser; Dan Tong; Reinhard Horvat; Alexander Reinthaller; Alexander Mustea; Robert Zeillinger
Journal:  BMC Cancer       Date:  2009-04-09       Impact factor: 4.430

View more
  13 in total

1.  Müllerian adenosarcoma arising from rectal endometriosis.

Authors:  Chunseok Yang; Hoon Kyu Oh; Daedong Kim
Journal:  Ann Coloproctol       Date:  2014-10-28

2.  Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk.

Authors:  Jaime L Matta; Idhaliz Flores; Luisa M Morales; Janice Monteiro; Carolina Alvarez-Garriga; Manuel Bayona
Journal:  Mol Cancer Biol       Date:  2013-12-20

Review 3.  Uterine Adenosarcoma: a Review.

Authors:  Michael J Nathenson; Vinod Ravi; Nicole Fleming; Wei-Lien Wang; Anthony Conley
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

Review 4.  [Endometriosis-related ovarian tumors].

Authors:  D Schmidt; U Ulrich
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

5.  Cyst fluid hemoglobin species in endometriosis and its malignant transformation: The role of metallobiology.

Authors:  Takuya Iwabuchi; Chiharu Yoshimoto; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

Review 6.  Oxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant Transformation.

Authors:  Takuya Iwabuchi; Chiharu Yoshimoto; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Oxid Med Cell Longev       Date:  2015-06-21       Impact factor: 6.543

7.  Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review).

Authors:  Chiharu Uekuri; Hiroshi Shigetomi; Sumire Ono; Yoshikazu Sasaki; Miyuki Matsuura; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2013-08-28       Impact factor: 2.967

8.  MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.

Authors:  Yukihiro Hirata; Noriyuki Murai; Nozomu Yanaihara; Misato Saito; Motoaki Saito; Mitsuyoshi Urashima; Yasuko Murakami; Senya Matsufuji; Aikou Okamoto
Journal:  BMC Cancer       Date:  2014-11-03       Impact factor: 4.430

9.  A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach.

Authors:  Myriam Anna Perrone; Margherita Nannini; Giulia Dondi; Donatella Santini; Antonio De Leo; Angelo Paolo Dei Tos; Claudio Zamagni; Maristella Saponara; Lidia Gatto; Concetta Nigro; Paola Bertaccini; Maurizio Zompatori; Pierandrea De Iaco; Anna Myriam Perrone; Maria Abbondanza Pantaleo
Journal:  Clin Med Insights Oncol       Date:  2018-06-18

10.  ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death.

Authors:  Mari Ueno; Takayuki Shiomi; Satsuki Mochizuki; Miyuki Chijiiwa; Masayuki Shimoda; Yae Kanai; Fumio Kataoka; Akira Hirasawa; Nobuyuki Susumu; Daisuke Aoki; Yasunori Okada
Journal:  Cancer Sci       Date:  2018-02       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.